• (000) 123 458 789
  • office@worldpatientsalliance.org

Introduction

Prediabetes is a growing public health concern that often goes unnoticed until it progresses to type 2 diabetes or leads to serious complications. Early identification and timely intervention can significantly reduce the risk of disease progression, yet awareness of early signs and risk factors remains limited in many communities.

This webinar on “Prediabetes Early Diagnosis and Symptoms Awareness,” to be held on April 30, 2026 at 8:00 AM EST, aims to bridge that gap by equipping patients & families, communities, and healthcare stakeholders with essential knowledge to recognize and respond to early warning signs. The session will begin with a comprehensive presentation covering both common and frequently overlooked symptoms, variations across different age groups and populations, and the influence of genetic, lifestyle, and environmental factors.

Participants will also gain insights into high-risk and vulnerable populations, the role of social determinants of health, and the importance of equitable access to screening and care. The webinar will further explore available screening tools, guidelines on who and when to screen, and how early diagnosis can prevent long-term complications through timely intervention and referral pathways.

The presentation will be followed by an interactive panel discussion, bringing together patients, families and experts to share practical perspectives, address challenges, and answer audience questions.

Join us as we work toward improving early detection, raising awareness, and strengthening preventive strategies to combat prediabetes effectively.

Agenda

Welcome and Opening Remarks

Andrew Spiegel | Chair, Board of Directors | WPA

Moderator

Hussain Jafri | CEO | WPA

Prediabetes Early Diagnosis and Symptoms Awareness

Dr. Kerstin MG Brand, Global Medical Director, Diabetes Portfolio

Panel Discussion

Moderator:

Hussain Jafri | CEO | WPA

Panelists:

Jackie Kassouf Maalouf | Vice President | International Diabetes Federation

Q&A Session

Closing Remarks

Hussain Jafri | CEO | WPA

Speakers

Dr. Kerstin MG Brand
Dr. Kerstin MG Brand
Global Medical Director for the diabetes portfolio at Merck KGaA Dr. Kerstin MG Brand is the Global Medical Director for the diabetes portfolio at Merck KGaA, Darmstadt, Germany. She leads medical lifecycle management for metformin, the key ingredient in the original metformin brand, Glucophage®. With over 20 years of experience in cardiometabolic drug development, Dr. Brand has successfully spearheaded multiple lifecycle innovation projects for metformin and other cardiometabolic therapies at Merck. She holds a Ph.D. in Clinical Pharmacology and Pharmaceutical Biology from the University of Bonn and is passionate about the interconnected functions of the body, particularly the insulin signaling pathway, as well as value-based innovation, women’s health, and medical storytelling.
Dr. Jackie Maalouf
Jackie Kassouf Maalouf, Ph.D.
Dr. Jackie Maalouf is Vice President at the International Diabetes Federation IDFserving on a second term, board member at the NCD Alliance, and board member at the GMHA, she is the Founder and President of Dialeb- The National Diabetes Organization, a leading diabetes organization in Lebanon which she founded with her daughter Sylvie living with type 1 diabetes in 2010. As of January 2026 she was appointed on the international board of the Global Metabolic Health Alliance GMHA. She is a certified diabetes educator. She made it her mission in life to advocate for those living with diabetes and other NCDs, and delivers educational and motivational talks around these topics across the globe. She has over 15 years of experience in leading Dialeb’s awareness campaigns and activities across Lebanon., and has earned several awards and certifications related to diabetes, nutrition, sports, public health… She has participated as a speaker at many local, regional, and international diabetes conferences. She takes parts as member at 3 committees at the global board of IDF, and is leading the sustainability committee since 2022. With IDF- MENA she is a member of several committees and has led the youth committee since 2022.She is an expert consultant with the WHO and sits on the boards of several local regional and global organizations, She has participated in many research papers as a co-author or reviewer. Dr. Jackie Maalouf is a seasoned educator who has taught for many years at the American University of Beirut (AUB) and AUCE. A passionate diabetes advocate and a staunch believer in social innovation, she frequently delivers talks at various forums, championing impactful initiatives. Her dedication to driving social change has earned her multiple awards of appreciation from local, regional, and international institutions. Fluent in four languages and proficient in two others, Dr. Maalouf excels in fostering global communication and collaboration. Guided by the principle of “Being the Change” and leading by example, she finds immense fulfillment in empowering communities to strive for a better future and a better quality of life.